KUALA LUMPUR: CCM DUOPHARMA BIOTECH BHD [] will focus on bioTECHNOLOGY [] and invest about 2% of its 2010 revenue in research and development to explore opportunities and leverage on this emerging lucrative niche market.
Its chairman Tan Sri Dr Abu Bakar Suleiman said on Thursday, May 26 this would include the manufacturing and commercialisation of biosimillars.
(Biosimilars or follow-on biologics are subsequent versions of innovator biopharmaceutical products made by a different sponsor following patent and exclusivity expiry on the innovator product).
He said the company also aims to continue to enhance its generic pharmaceuticals portfolio and capitalise on the promising growth opportunities arising from the strong demand for generics which is currently valued at RM1 billion as well as to venture further into the regional markets.
'Demand for high quality and affordable pharmaceuticals and healthcare products is growing at a healthy rate and CCMD is poised to take full advantage of this opportunity,' he added.
Dr Abu Bakar also said CCMD was leveraging on Malaysia's position as a global halal industry hub with its range of halal products which meets stringent halal manufacturing requirements.
He added that its products had attracted encouraging interest from both Muslim and non-Muslim consumers.
Its chairman Tan Sri Dr Abu Bakar Suleiman said on Thursday, May 26 this would include the manufacturing and commercialisation of biosimillars.
(Biosimilars or follow-on biologics are subsequent versions of innovator biopharmaceutical products made by a different sponsor following patent and exclusivity expiry on the innovator product).
He said the company also aims to continue to enhance its generic pharmaceuticals portfolio and capitalise on the promising growth opportunities arising from the strong demand for generics which is currently valued at RM1 billion as well as to venture further into the regional markets.
'Demand for high quality and affordable pharmaceuticals and healthcare products is growing at a healthy rate and CCMD is poised to take full advantage of this opportunity,' he added.
Dr Abu Bakar also said CCMD was leveraging on Malaysia's position as a global halal industry hub with its range of halal products which meets stringent halal manufacturing requirements.
He added that its products had attracted encouraging interest from both Muslim and non-Muslim consumers.
No comments:
Post a Comment